Job Calis (Amsterdam UMC) and Mark Hoogendoorn (VU): IMPALA
Job Calis (Amsterdam UMC) and Mark Hoogendoorn (VU): IMPALA: Innovative Monitoring system for PAediatrics in Low-resource settings: an Aid to save lives.
Each year, more than 3 million children die in poor countries. At least half of these deaths can be prevented by early recognition, before patients deteriorate. In Europe, patient monitors are used to continuously watch patients. Monitors could be especially useful in Africa, where there are many patients and only few nurses. IMPALA monitors have been developed for use in the African context using contactless sensors, robust hardware and a tablet based overview. Predictive AI driven algorithms for African children, combine patient characteristics, monitoring data and novel biomarkers in order to detect and, more importantly, predict deterioration allowing for earlier interventions and improving child survival.
Explore other Cases:
John van der Kamp and Boris Lancelot (VU): Lentala
John van der Kamp and Boris Lancelot (VU): Rom & Lupa designed by Lentala: school furniture for active sitting Today, children move too little and sit too much, especially a school classrooms. Prolonged passive sitting is a risk factor for poor physical health and low mental well-being. The human body has evolved to move and […]
Paul Merkus (Amsterdam UMC): BoneMRI of the head
Paul Merkus (Amsterdam UMC): BoneMRI of the head There are many young patients that face deafness and need surgery to be able to hear. Before the surgery, the ENT-surgeon currently needs two scans: an MRI to visualize the soft tissues like nerves, and a CT scan to show the bony structures. However, the CT scanning […]
Ewelina Weglarz-Tomczak (UvA): Lysosomal protease inhibitors for Alzheimer’s
Ewelina Weglarz-Tomczak (UvA): Novel lysosomal protease inhibitors for the treatment of Alzheimer’s disease Highly specified proteases are the key regulators in the molecular mechanism of neurodegeneration in Alzheimer’s disease. AI-powered technology developed by NatInLab has led to the discovery of how those proteases are controlled in the human organism. Based on this knowledge, developing novel, […]